Biggest News Aggregation in the World
📰 Broad Phase News

Broad Phase News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Broad Phase. Real-time updates on events, politics, business and more.

Cytokinetics Presents Additional 48-Week Data From FOREST-HCM, the Open Label Extension ...

SOUTH SAN FRANCISCO, Calif., April 05, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced additional 48-week data from FOREST-HCM (Follow-up, Open-Label, Research Evaluation of Sustained Treatment with Aficamten
United States Fadyi Malik Diane Weiser Clinical Trials Program For Aficamten American College Of Cardiology Corporate Affairs

Cytokinetics Announces Positive Results From SEQUOIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy -December 27, 2023 at 07:31 am EST

Statistically Significant and Clinically Meaningful Increasein Primary Efficacy Endpoint at 24 Weeks of Treatment; Improvement Consistent Across All Prespecified Subgroups Statistically Significant...
United States Fadyi Malik Diane Weiser Martin Maron Tufts University School Of Medicine Exchange Commission

Cytokinetics Provides Update on Cardiac Myosin Inhibitor Programs and Plans to Build a Specialty Cardiology Franchise at Virtual Investor & Analyst Day

New Long-Term Data from FOREST-HCM, the Open-Label Extension Study of Aficamten,Show Sustained Improvements in Clinical Efficacy Endpointsand No Treatment Interruptions for Low Ejection Fraction ...
San Francisco United States Theodore Abraham Roberti Blum Diane Weiser Cytokinetics Incorporated Nasdaq

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Cytokinetics Announces Start of ACACIA-HCM, a Pivotal Phase 3 Clinical Trial of Aficamten in ...

SOUTH SAN FRANCISCO, Calif., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that ACACIA-HCM (Assessment Comparing Aficamten to Placebo on Cardiac Endpoints In Adults with Non-Obstructive
United States Fadyi Malik Diane Weiser Cytokinetics Incorporated Nasdaq York Heart Association Us Food Drug Administration

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science